End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
27.6
CNY
|
+20.00%
|
|
+15.58%
|
+389.36%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,411
|
2,406
|
2,581
|
3,403
|
2,470
|
2,742
|
Enterprise Value (EV)
1 |
2,052
|
2,269
|
2,401
|
3,151
|
2,194
|
2,399
|
P/E ratio
|
41.3
x
|
61.9
x
|
59
x
|
33.3
x
|
46.2
x
|
282
x
|
Yield
|
0.81%
|
0.4%
|
0.38%
|
0.71%
|
0.98%
|
0.35%
|
Capitalization / Revenue
|
1.99
x
|
1.84
x
|
1.96
x
|
1.93
x
|
1.28
x
|
1.78
x
|
EV / Revenue
|
1.7
x
|
1.74
x
|
1.82
x
|
1.79
x
|
1.14
x
|
1.56
x
|
EV / EBITDA
|
22.5
x
|
32
x
|
29.4
x
|
16.9
x
|
19.9
x
|
42.2
x
|
EV / FCF
|
-8.91
x
|
-10
x
|
75.2
x
|
454
x
|
73.5
x
|
31.4
x
|
FCF Yield
|
-11.2%
|
-10%
|
1.33%
|
0.22%
|
1.36%
|
3.19%
|
Price to Book
|
1.85
x
|
1.82
x
|
1.9
x
|
2.28
x
|
1.6
x
|
1.79
x
|
Nbr of stocks (in thousands)
|
486,126
|
486,126
|
486,126
|
486,127
|
486,130
|
486,131
|
Reference price
2 |
4.960
|
4.950
|
5.310
|
7.000
|
5.080
|
5.640
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/15/21
|
4/6/22
|
4/25/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,210
|
1,308
|
1,318
|
1,759
|
1,924
|
1,538
|
EBITDA
1 |
91.23
|
70.91
|
81.6
|
187
|
110.2
|
56.79
|
EBIT
1 |
54.49
|
38.17
|
46.52
|
127.9
|
48.89
|
-12.61
|
Operating Margin
|
4.51%
|
2.92%
|
3.53%
|
7.27%
|
2.54%
|
-0.82%
|
Earnings before Tax (EBT)
1 |
69.02
|
45.74
|
48.71
|
121.1
|
65.17
|
9.123
|
Net income
1 |
60.34
|
40.45
|
43
|
104.5
|
55.83
|
9.875
|
Net margin
|
4.99%
|
3.09%
|
3.26%
|
5.94%
|
2.9%
|
0.64%
|
EPS
2 |
0.1200
|
0.0800
|
0.0900
|
0.2100
|
0.1100
|
0.0200
|
Free Cash Flow
1 |
-230.4
|
-227
|
31.95
|
6.935
|
29.83
|
76.42
|
FCF margin
|
-19.05%
|
-17.36%
|
2.42%
|
0.39%
|
1.55%
|
4.97%
|
FCF Conversion (EBITDA)
|
-
|
-
|
39.15%
|
3.71%
|
27.07%
|
134.56%
|
FCF Conversion (Net income)
|
-
|
-
|
74.3%
|
6.64%
|
53.43%
|
773.86%
|
Dividend per Share
2 |
0.0400
|
0.0200
|
0.0200
|
0.0500
|
0.0500
|
0.0200
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/15/21
|
4/6/22
|
4/25/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
359
|
137
|
180
|
252
|
276
|
343
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-230
|
-227
|
31.9
|
6.93
|
29.8
|
76.4
|
ROE (net income / shareholders' equity)
|
4.61%
|
3.08%
|
3.2%
|
7.3%
|
3.66%
|
0.64%
|
ROA (Net income/ Total Assets)
|
2.16%
|
1.45%
|
1.73%
|
4.06%
|
1.36%
|
-0.36%
|
Assets
1 |
2,791
|
2,792
|
2,489
|
2,572
|
4,094
|
-2,773
|
Book Value Per Share
2 |
2.680
|
2.730
|
2.800
|
3.070
|
3.170
|
3.150
|
Cash Flow per Share
2 |
0.7800
|
0.6400
|
0.7700
|
1.550
|
1.060
|
1.640
|
Capex
1 |
248
|
104
|
35.8
|
103
|
52.6
|
65.7
|
Capex / Sales
|
20.53%
|
7.97%
|
2.71%
|
5.88%
|
2.73%
|
4.27%
|
Announcement Date
|
4/25/19
|
4/26/20
|
4/15/21
|
4/6/22
|
4/25/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| +389.36% | 1.86B | | +6.11% | 106B | | -4.67% | 63.67B | | +73.81% | 49.32B | | +15.46% | 38.56B | | +5.46% | 32.65B | | +11.59% | 20.08B | | +13.74% | 17.01B | | +20.05% | 15.41B | | +5.02% | 14.41B |
Other Commodity Chemicals
|